StrokeNCT07018167
Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital
An observational study of Stroke and Ischemic Attack, Transient, run by Centre Hospitalier de Gonesse at 1 site in France.
Trial summary
This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Stroke, Ischemic Attack, Transient, Cerebral Infarction
- How many people
- 61 participants
- Where
- 1 siteFrance
- Study dates
- 1 May 2025to 1 Sep 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: The study population will consist of adult patients (aged 18 and over) admitted to the Gonesse Hospital for acute ischemic stroke. All participants must have received intravenous thrombolysis (r-tPA) initiated at the hospital during the 3-month study period. Only patients with complete clinical and time-tracking data enabling the calculation of Door-to-Needle Time will be included.
Who may be able to join
- Patients aged 18 years or older
- Confirmed diagnosis of acute ischemic stroke on imaging
- Initial acute stroke care provided at Gonesse Hospital during the study period (3 months)
- Intravenous thrombolysis (r-tPA) initiated at the hospital
- Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)
Who cannot join
- Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH)
- Thrombolysis initiated before hospital arrival
- Missing, incomplete, or unusable timing data for DNT calculation
Trial locations and contacts
1 site in 1 country.
About this study
This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.
- Conditions
- Stroke, Ischemic Attack, Transient, Cerebral Infarction, Thrombolytic Therapy, Treatment Outcome
- Medical subject headings
- Stroke, Ischemic Attack, Transient, Cerebral Infarction
What is being measured
The primary outcome is the main question the study is designed to answer.
Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2025
- Study start1 May 2025
- Primary completion1 Sep 2025 (estimated)
- Study completion1 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 61 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Gonesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07018167
- Sponsor's protocol ID
- 0107_NEUROLOGIE
- Status last verified
- May 2025
- First submitted
- 21 May 2025
- Last updated
- 12 Jun 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital
- ClinicalTrials.gov ID
- NCT07018167
- Acronym / sponsor ID
- 0107_NEUROLOGIE
- Conditions
- Stroke, Ischemic Attack, Transient, Cerebral Infarction, Thrombolytic Therapy, Treatment Outcome
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 61 participants (estimated)
- Lead sponsor
- Centre Hospitalier de GonesseUniversity, hospital or other
- Study start
- 1 May 2025 (actual)
- Primary completion
- 1 Sep 2025 (estimated)
- Study completion
- 1 Sep 2025 (estimated)
- First posted
- 12 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- The study population will consist of adult patients (aged 18 and over) admitted to the Gonesse Hospital for acute ischemic stroke. All participants must have received intravenous thrombolysis (r-tPA) initiated at the hospital during the 3-month study period. Only patients with complete clinical and time-tracking data enabling the calculation of Door-to-Needle Time will be included.
Key inclusion criteria (5 listed)
- Patients aged 18 years or older
- Confirmed diagnosis of acute ischemic stroke on imaging
- Initial acute stroke care provided at Gonesse Hospital during the study period (3 months)
- Intravenous thrombolysis (r-tPA) initiated at the hospital
- Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)
Key exclusion criteria (3 listed)
- Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH)
- Thrombolysis initiated before hospital arrival
- Missing, incomplete, or unusable timing data for DNT calculation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).
Time frame: 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2025.
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke and Ischemic Attack, Transient, run by Centre Hospitalier de Gonesse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 12 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time). (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2025.